Anish Maskey | Immunology and Microbiology | Best Researcher Award

Posted on by World Top Scientists

Dr. Anish Maskey | Immunology and Microbiology | Best Researcher Award

Postdoctoral Fellow at New York Medical College, United States

Dr. Anish R. Maskey is a dedicated postdoctoral fellow at the Department of Pathology, Microbiology & Immunology at New York Medical College, with a specialized focus on allergy, immunology, and infectious diseases. With an in-depth understanding of translational research, he integrates bench-to-bedside approaches, concentrating on biomarker discovery, immune response profiling, and therapeutic evaluation for allergic and inflammatory conditions. Over the past six years, he has built a strong scientific portfolio in both academic and clinical research settings, with active involvement in designing, executing, and analyzing preclinical studies using in-vitro systems, human samples, and murine models. His collaborative nature and leadership skills are evident through his mentorship of over 25 trainees, active role in multi-institutional conferences, and contribution to peer-reviewed journals. Dr. Maskey’s publication record includes multiple first-author and collaborative studies in prominent journals like Frontiers in Allergy, Cells, and The Journal of Inflammation Research. His scientific acumen is matched by his commitment to education and community-building in science. As a member of multiple professional societies and editorial boards, he continues to shape the future of immunological research while fostering international collaboration and integrative medical approaches. His work represents a blend of scientific excellence, innovation, and societal impact.

Professional Profile

Education

Dr. Anish R. Maskey holds a Ph.D. in Pathology, Microbiology, and Immunology from New York Medical College, which he earned in 2023 with a commendable CGPA of 3.75/4. His doctoral research was centered on discovering small molecule compounds—particularly from Traditional Chinese Medicine—as novel therapeutics for eosinophilic esophagitis. This body of work laid the foundation for his expertise in allergic diseases, immunomodulation, and translational medicine. Prior to his Ph.D., Dr. Maskey completed his Bachelor of Science in Medical Laboratory Technology from the Institute of Medicine in Kathmandu, Nepal, graduating in 2016 with a strong academic record of 72%. His educational journey reflects a continual evolution from clinical laboratory sciences to cutting-edge immunological research, underpinned by rigorous training in microbiology, molecular biology, and clinical diagnostics. Beyond formal education, he has also actively pursued professional development through certifications in clinical trial ethics, laboratory safety, peer reviewing, and biomedical research compliance under platforms such as CITI and Elsevier. These educational milestones not only showcase Dr. Maskey’s technical proficiency but also his commitment to lifelong learning, scientific integrity, and the ethical conduct of human and animal research. His academic background enables him to operate seamlessly at the intersection of clinical science and laboratory innovation.

Professional Experience

Dr. Maskey currently serves as a postdoctoral fellow at New York Medical College, where he works under the mentorship of Dr. Xiu-Min Li on multiple NIH-funded projects related to allergic diseases, microbiome therapy, and drug discovery. He is the Co-Investigator or Co-Principal Investigator on several high-impact translational research studies involving human clinical samples and murine models. His work explores the therapeutic efficacy of natural compounds on conditions such as eczema, food allergies, eosinophilic esophagitis, and antibiotic-resistant infections. Previously, during his Ph.D. candidacy (2018–2023), he led key investigations on chronic inflammatory diseases and mentored junior researchers while also teaching advanced immunology and microbiology courses. Dr. Maskey has authored or co-authored over 15 peer-reviewed publications and actively contributes as an editorial board member and peer reviewer for journals such as Frontiers in Allergy and The FASEB Journal. In his leadership roles, he has managed research teams, coordinated research conferences, and overseen protocol development and compliance for IRB and IACUC projects. His professional experience reflects a dynamic integration of teaching, research, mentorship, and administration, underlining his preparedness for independent academic or industry-based scientific leadership roles in immunology, microbiology, and translational medicine.

Research Interests

Dr. Anish R. Maskey’s research interests span allergy and immunology, host-pathogen interactions, microbiome-based therapy, and immune modulation using natural compounds. His primary focus lies in discovering and validating biomarkers for allergic diseases, including food allergies, eczema, eosinophilic esophagitis, and drug-resistant infections. Dr. Maskey is particularly interested in translational and integrative approaches to treating chronic inflammation by bridging clinical medicine with basic science. Through his ongoing work on immune profiling, he explores cytokine signaling, IgE-mediated hypersensitivity, mast cell activation, and epigenetic regulation of Th2 responses. He has established various murine models for food allergies, eczema, and Staphylococcus aureus infections to test the efficacy and mechanisms of plant-based therapeutics like berberine and ganoderic acid. Additionally, he investigates the skin and gut microbiomes’ roles in disease progression and recovery, utilizing both in-vivo and ex-vivo models. His interest also extends to nanoparticle drug delivery and immune memory formation. Dr. Maskey’s ultimate goal is to facilitate the development of safer, non-steroidal treatment options that are effective, personalized, and rooted in natural product pharmacology. His work contributes meaningfully to both the scientific community and clinical practice, offering promising alternatives for managing and preventing allergic and inflammatory disorders.

Awards and Honors

Dr. Anish R. Maskey has been the recipient of numerous prestigious awards and honors recognizing his academic excellence, innovative research, and impactful scientific contributions. He has won multiple travel scholarships from the American Academy of Allergy, Asthma & Immunology (AAAAI) from 2022 to 2025, allowing him to present his research at major national conferences. In 2023, he received the APFED travel grant and earned the Outstanding Abstract Award at Touro Research Day in 2024. He also secured second place for oral abstract presentation at the 1st PMI Conference at New York Medical College and was a runner-up in the ASBMB’s “Science in a Flash” competition. His publications have gained recognition as Top Cited and Top Downloaded articles by WILEY and The FASEB Journal. Furthermore, Dr. Maskey has been appointed as an Editorial Board Member for the International Journal of Infectious Diseases and Therapy and The FASEB Journal’s Early Career Researcher Board. His service as a peer reviewer for journals under Cell Press, Frontiers, MDPI, and Dove Medical Press further underscores his credibility and scientific leadership. These accolades collectively affirm his rising influence in the fields of immunology and translational medicine.

Conclusion

Dr. Anish R. Maskey is an outstanding candidate for the Best Researcher Award, especially in the category of early-career/postdoctoral researchers. His contributions to the fields of immunology and infectious diseases are substantive, innovative, and multidisciplinary. His leadership in research, commitment to mentoring, and active scholarly engagement make him exceptionally deserving of recognition.

Publications Top Notes

  • Title: A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS
    First Author: Wang ZZ
    Year: 2021
    Citations: 68

  • Title: Cytochrome P450 3A4 suppression by epimedium and kaempferol leads to synergistic anti-inflammatory effect with corticosteroid
    First Author: Li K
    Year: 2023
    Citations: 12

  • Title: Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and berberine with immunometabolism regulation
    First Author: Yang N
    Year: 2023
    Citations: 11

  • Title: Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens
    First Author: Maskey A
    Year: 2022
    Citations: 9

  • Title: Formononetin inhibits B cell-IgE production by regulating XBP-1
    First Author: Yang N
    Year: 2023
    Citations: 7

  • Title: Anti-IgE effect of arctigenin on food allergy with a distinct transcriptome profile
    First Author: Cao M
    Year: 2022
    Citations: 6

  • Title: Computational analysis of 7,4’-Dihydroxyflavone on eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 3

  • Title: Efficacy of Ganoderic Acid C1 on corticosteroid-resistant neutrophilic airway inflammation
    First Author: Wang ZZ
    Year: 2024
    Citations: 2

  • Title: Berberine inhibits inflammatory response by S. aureus in atopic eczema
    First Author: Maskey AR
    Year: 2024
    Citations: 2

  • Title: Potency and chemical consistency of FAHF-2 for food allergy treatment
    First Author: Maskey A
    Year: 2020
    Citations: 2

  • Title: The gut microbiome and cross-reactivity of food allergens
    First Author: Taico Oliva C
    Year: 2025
    Citations: 1

  • Title: Preclinical models of atopic dermatitis for therapeutic investigations
    First Author: Maskey AR
    Year: 2024
    Citations: 1

  • Title: Berberine’s potential in attenuating S. aureus-induced inflammation
    First Author: Kwan M
    Year: 2024
    Citations: 1

  • Title: 7,4 Dihydroxy Flavone for treatment of eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 1

  • Title: Biomarkers and neurobiomarkers in allergic contact dermatitis
    First Author: Sasaki A
    Year: 2025
    Citations: Not listed

  • Title: Roles of bitter and sweet taste receptors in food allergy
    First Author: Xian M
    Year: 2025
    Citations: Not listed

 

Wael El-Sayed | Microbiology | Best Research Article Award

Posted on by World Top Scientists

Prof Dr. Wael El-Sayed | Microbiology | Best Research Article Award

Professor, Ain Shams University, Egypt

Dr. Wael M. El-Sayed is a distinguished Professor of Toxicology and Physiology with over 30 years of experience in research, education, and mentorship. He has made significant contributions to the fields of toxicology, drug development, and molecular biology, particularly in understanding the therapeutic mechanisms of natural products. His academic journey has taken him from Cairo to Salt Lake City, and his work continues to impact the global scientific community.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Experience:
    • Dr. El-Sayed has over 30 years of experience in physiology, toxicology, drug development, molecular biology, natural products, and tissue culture research. This extensive background demonstrates his deep knowledge and expertise in these fields.
  2. Diverse Research Interests:
    • His research spans a wide range of topics, including natural products, drug-drug interactions, chemoprotection strategies in cancer, antioxidants, and biochemical and molecular toxicology. This diversity reflects his ability to contribute to various research areas, which can be a significant advantage for a “Best Research Article Award.”
  3. High-Impact Publications:
    • Dr. El-Sayed has published research in reputable journals, such as Frontiers in Oncology and Journal of King Saud University – Science, which indicates the quality and relevance of his work. His recent studies on topics like the miRNome of hepatocellular carcinoma and potential COVID-19 inhibitors showcase his involvement in cutting-edge research.
  4. International Collaboration:
    • He has collaborated with researchers from different countries and institutions, including the University of Utah, USA, and King Faisal University, Saudi Arabia. This international exposure enriches his research perspectives and broadens the impact of his work.
  5. Recent and Relevant Publications:
    • The publication dates of his work, particularly in 2022 and 2023, indicate that Dr. El-Sayed is actively engaged in current research, which is crucial for winning an award for the best research article.

Areas for Improvement

  1. Focus on Breakthrough Research:
    • While Dr. El-Sayed’s research is diverse and impactful, the award committee might prioritize groundbreaking or highly innovative work. Emphasizing and furthering research that introduces novel concepts or significantly advances existing knowledge could strengthen his candidacy.
  2. Citation Impact and Recognition:
    • Although Dr. El-Sayed has published in high-quality journals, the impact of these publications, such as citation counts or recognition in the scientific community, could be further highlighted. Demonstrating the influence of his work on the field would reinforce his qualifications for the award.
  3. Enhanced Dissemination:
    • To increase the visibility and impact of his research, Dr. El-Sayed could focus on disseminating his findings through conferences, workshops, and broader media, enhancing the accessibility and application of his work beyond academic circles.

Education 🎓

Dr. El-Sayed earned his Ph.D. in Toxicology from Ain Shams University, Egypt, in collaboration with the College of Pharmacy, University of Utah, USA. His doctoral research focused on the “Mechanisms of therapeutic activities of Nigella Sativa against lipid peroxidation and hepatotoxicity in male albino rats.” Prior to this, he completed his M.Sc. in Physiology from Ain Shams University, where he explored the “Effect of Nigella Sativa on some physiological and biochemical parameters in male albino rats.” He also holds a B.Sc. in Science from Ain Shams University.

Experience 🧪

Dr. El-Sayed has held several key academic positions throughout his career. Since 2014, he has been a Professor at the Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt. He previously served as an Associate Professor at the same department (2009-2014) and at the Biology Department, King Faisal University, Saudi Arabia (2007-2013). His early academic career includes his role as an Assistant Professor at Ain Shams University (2003-2009).

Research Interests 🔬

Dr. El-Sayed’s research spans a broad spectrum of scientific domains, including:

  • Natural products: Investigating therapeutic properties from plant and animal sources.
  • Drug-drug interactions: Understanding how drugs interact and their metabolic pathways.
  • Novel drug evaluation: Assessing the efficacy and safety of new pharmaceuticals.
  • Cancer chemoprotection: Developing strategies for cancer prevention and treatment.
  • Antioxidants: Exploring their role in health and disease.
  • Molecular toxicology: Studying the biochemical and molecular effects of toxins.

Awards 🏆

Dr. El-Sayed’s dedication to scientific research and education has earned him recognition in the academic community. His innovative work in toxicology and natural products has positioned him as a leader in his field, contributing to numerous advancements that have been acknowledged by peers and institutions worldwide.

Publications Top Notes 📚

Dr. El-Sayed has authored numerous impactful publications. Some of his recent notable works include:

miRNome of Child A hepatocellular carcinoma in Egyptian patients – Frontiers in Oncology, 2023. DOI: 10.3389/fonc.2023.1137585
Cited by multiple studies exploring hepatocellular carcinoma.

1,4,9,9-tetramethyloctahydro-4,7-(epoxymethano)azulen-5(1H)-one, a natural product as a potential inhibitor of COVID-19 – Journal of King Saud University – Science, 2023. DOI: 10.1016/j.jksus.2023.102628
Referenced in research on antiviral drug development.

Investigating the Antifertility Efficacy of Testosterone on Male and Female Albino Mice – Pakistan Journal of Zoology, 2023. DOI: 10.17582/journal.pjz/20211107091104
Contributed to studies on reproductive health.

New Benzochromeno[2,3-d]pyrimidines and Benzochromenotriazolo[1,5-c]pyrimidines as Potential Inhibitors of Topoisomerase II – Polycyclic Aromatic Compounds, 2022. DOI: 10.1080/10406638.2021.2006247
Cited in cancer research for topoisomerase inhibitors.

Conclusion

Dr. Wael M. El-Sayed is a highly qualified candidate for the “Best Research Article Award,” given his extensive experience, diverse research interests, and recent high-impact publications. His work contributes significantly to the fields of toxicology, drug development, and natural products, making him a strong contender. However, to maximize his chances, he may benefit from emphasizing the novelty and broader impact of his research, as well as enhancing its visibility within the scientific community. Overall, his credentials and contributions align well with the criteria for the award, making him a suitable candidate.

Dr. Sanaz Ahmadi | Immunology and Microbiology | Best Researcher Award

Posted on by World Top Scientists

Dr. Sanaz Ahmadi | Immunology and Microbiology | Best Researcher Award

Dr. Sanaz Ahmadi, Academic Center for Education, Culture and Research, Iran

Sanaaz Ahmadi Ghazal Dasht, born on June 23, 1980, in Shahroud, is a married individual with two children. She holds a Ph.D. in Medical Sciences specializing in Medical Immunology from Mashhad University, where she completed her doctoral thesis on the production of the protease-1HTLV protein in Pichia pastoris for potential therapeutic applications in HTLV-related diseases. With 15 years of professional experience, she is currently affiliated with the Center for Research on Bloodborne Infections at the University Jihad Daneshgahi Khorasan Razavi in Mashhad. Sanaaz has a Master’s degree in Animal Biology with a focus on Physiology from Payam Noor University in Isfahan and a Bachelor’s degree in General Biology for Teachers from Sabzevar University. Her research during her master’s studies explored the impact of collagen type I on cellular growth and differentiation in culture environments. Sanaaz’s educational journey also includes investigating cartilage repair in a rabbit ear model during her bachelor’s studies. Additionally, she has demonstrated proficiency in language, obtaining a score of 73 in the MSRT language exam in 2015.

🌐 Professional Profiles :

Scopus

Google Scholar

📚 Education:

  • 🎓 Ph.D. in Medical Sciences, Mashhad University, Immunology, 1401
  • 🎓 M.Sc. in Biology (Animal Physiology), Payam-e-Noor University, Isfahan, 1385
  • 🎓 B.Sc. in Education (Biology), Sabzevar University, 1381

🔬 Research Projects:

  • 📝 Ph.D. Project: Production of HTLV-1 Protease Protein Linked to Human IgG1 Fcγ in Pichia Pastoris for In Vitro and In Vivo Inhibition Studies in Mouse Models.
    • 🧑‍🔬 Supervisor: Dr. Seyed Abdolrahim Rezaei
  • 📝 M.Sc. Project: Investigating the Effect of Type I Collagen on Cellular Growth and Differentiation in Culture Medium.
    • 🧑‍🔬 Supervisor: Dr. Mohsen Fattahi Najafi
  • 📝 B.Sc. Project: Study on Cartilage Repair in Rabbit Ear Model.
    • 🧑‍🔬 Supervisor: Dr. Naser Mahdavi Shahr i

🌐 Research Interests :

Sanaaz Ahmadi Ghazal Dasht has a profound passion for her research, focusing particularly on HTLV-1 (Human T-Cell Lymphotropic Virus Type 1) and ATLL (Adult T-Cell Leukemia/Lymphoma). Her expertise lies in exploring the intricate connections between HTLV-1 and the development of ATLL, striving to unravel the complexities of these viral-induced malignancies. With a commitment to understanding the underlying mechanisms, her work holds the potential to contribute significantly to advancements in the field of oncovirology.

Publications Top Notes  :

  1. High Prevalence of HTLV-I Infection in Mashhad, Northeast Iran: A Population-Based Seroepidemiology Survey
    • Published in the Journal of Clinical Virology (2011)
    • Cited by 192
  2. Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T Cell Leukemia/Lymphoma (ATL)
    • Published in the Iranian Journal of Basic Medical Sciences (2013)
    • Cited by 76
  3. The Prevalence of Hepatitis B Antigen-Positivity in the General Population of Mashhad, Iran
    • Published in Hepatitis Monthly (2011)
    • Cited by 60
  4. Prevalence, Genotypes and Phylogenetic Analysis of Human Papillomaviruses (HPV) in Northeast Iran
    • Published in the International Journal of Infectious Diseases (2021)
    • Cited by 23
  5. T Regulatory Markers Expression in Unexplained Recurrent Spontaneous Abortion
    • Published in The Journal of Maternal-Fetal & Neonatal Medicine (2016)
    • Cited by 20